Robert Camerlinck is COO at Cano Health, Inc. (CANO). They have made 1 open-market trade across 1 company since 2023, most recently 2024-06-28.
CIK 0001942114
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| CANO | 26,958,642 | $62.0M |
Shares reported on the most recent Form 4, priced at the 2023-08-15 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| CANO | SELL | 2023-08-11 | 2023-08-15 | $0.77 | $24K | -27.5% | -20.8% | -84.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.